Neurology Publications
Patients with dementia with Lewy bodies display a signature alteration of their cognitive connectome;
Yanez-Perez, R, Garcia-Cabello, E, Habich, A, Cedres, N, Diaz-Galvan, P, Abdelnour, C, Toledo, JB, Barroso, J & Ferreira, D 2025, , Scientific Reports, vol. 15, no. 1, 940. https://doi.org/10.1038/s41598-024-84946-4
Patent Foramen Ovale and Atrial Septal Defect;
Aoun, J, Hatab, T, Volpi, J & Lin, CH 2025, , Interventional Cardiology Clinics, vol. 14, no. 3, pp. 395-410. https://doi.org/10.1016/j.iccl.2024.09.001
The annual economic burden of patent foramen ovale-associated stroke in the United States;
Volpi, JJ, Kasner, SE, Neervoort, J, Wolters, LF, Louwsma, T, Marti, AK & Landaas, EJ 2025, , Journal of Stroke and Cerebrovascular Diseases, vol. 34, no. 6, 108319. https://doi.org/10.1016/j.jstrokecerebrovasdis.2025.108319
A parametric study of motion and attachment to capillary walls of circulating tumor cells (CTCs) interacting with non-activated and activated platelets;
Simic, V, Nikolic, A, Ning, S, Milosevic, M, Leonard, F, Liu, X & Kojic, M 2025, , Computer Methods and Programs in Biomedicine, vol. 264, 108699. https://doi.org/10.1016/j.cmpb.2025.108699
A validation study of the Clinician's Tardive Inventory (CTI);
Trosch, RM, Shillington, AC, Comella, CL, Caroff, SN, Ondo, WG, LaChappelle, BJ, Harshaw, Q, Hauser, RA, Correll, CU & Friedman, JH 2025, , Parkinsonism and Related Disorders, vol. 135, 107812. https://doi.org/10.1016/j.parkreldis.2025.107812
Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer’s disease and synucleinopathies;
Colloby, SJ, McAleese, KE, Walker, L, Erskine, D, Toledo, JB, Donaghy, PC, McKeith, IG, Thomas, AJ, Attems, J & Taylor, JP 2025, , Brain, vol. 148, no. 5, pp. 1562-1576. https://doi.org/10.1093/brain/awae372
ACR Appropriateness Criteria® Dementia: 2024 Update;
Expert Panel on Neurological Imaging 2025, , Journal of the American College of Radiology, vol. 22, no. 5, pp. S202-S233. https://doi.org/10.1016/j.jacr.2025.02.031
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory;
Timilsina, S, Huang, JY, Abdelfattah, N, Medina, D, Singh, D, Abdulsahib, S, Subbarayalu, P, Do, TP, Venkata, PP, Nirzhor, S, Prochnau, J, Bhandari, M, Zheng, S, Chen, Y, Huang, G, Mukherjee, N, Hromas, R, Sung, P, Kaklamani, V, Vadlamudi, R, Zhang, N & Rao, MK 2025, , Nature Communications, vol. 16, no. 1, 3967, pp. 3967. https://doi.org/10.1038/s41467-025-59186-3
Glucagon-like peptide-1 agonism in combination with low-dose interleukin 2 enhances regulatory T cell suppressive function in vitro;
Thome, AD, Thonhoff, JR, Wang, J & Appel, SH 2025, , NeuroImmune Pharmacology and Therapeutics. <https://www.degruyterbrill.com/document/doi/10.1515/nipt-2025-0001/html>
Nuclear respiratory factor-1 (NRF1) induction as a powerful strategy to deter mitochondrial dysfunction and senescence in mesenchymal stem cells;
Lee, H, Massaro, M, Abdelfattah, N, Baudo, G, Liu, H, Yun, K & Blanco, E 2025, , Aging Cell, vol. 24, no. 4, pp. e14446. https://doi.org/10.1111/acel.14446